These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6353067)

  • 1. The effect of iron on mixed infection of Bacteroides fragilis and Escherichia coli in mice.
    Ward CG; Mitchell M; Streitfeld MM
    J Surg Res; 1983 Oct; 35(4):351-3. PubMed ID: 6353067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis.
    Rotstein OD; Pruett TL; Simmons RL
    Arch Surg; 1985 Feb; 120(2):146-51. PubMed ID: 3156575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection.
    Beale AS; Gisby J
    J Antimicrob Chemother; 1989 Jul; 24(1):29-37. PubMed ID: 2674099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots.
    Dunn DL; Rotstein OD; Simmons RL
    Arch Surg; 1984 Feb; 119(2):139-44. PubMed ID: 6365029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous injection of mice with bacteroides fragilis and Escherichia coli: role of Thioglycollate medium in the infectious process.
    Rodloff AC; Rodloff S; Fischer B; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 May; 254(3):405-12. PubMed ID: 6372324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.
    Schaumann R; Blatz R; Beer J; Ackermann G; Rodloff AC
    J Antimicrob Chemother; 2004 Feb; 53(2):318-24. PubMed ID: 14729746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of ceftriaxone in experimental infections involving Bacteroides fragilis and Escherichia coli.
    Dezfulian M; Bitar RA; Bartlett JG
    Chemotherapy; 1993; 39(5):355-60. PubMed ID: 8370326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin- resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique.
    Stearne LE; Kooi C; Goessens WH; Bakker-Woudenberg IA; Gyssens IC
    Antimicrob Agents Chemother; 2001 Jan; 45(1):243-51. PubMed ID: 11120973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of exogenous iron on Escherichia coli septicemia of turkeys.
    Bolin CA
    Am J Vet Res; 1986 Aug; 47(8):1813-6. PubMed ID: 3530066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses.
    Dunn DL; Barke RA; Ewald DC; Simmons RL
    Infect Immun; 1985 May; 48(2):287-91. PubMed ID: 3886544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli hemoglobin protease autotransporter contributes to synergistic abscess formation and heme-dependent growth of Bacteroides fragilis.
    Otto BR; van Dooren SJ; Dozois CM; Luirink J; Oudega B
    Infect Immun; 2002 Jan; 70(1):5-10. PubMed ID: 11748157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
    Wells CL; Arland LA; Simmons RL; Rotstein OD
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic lethality in experimental infections with Escherichia coli and Bacteroides fragilis.
    Rodloff AC; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Oct; 258(1):112-9. PubMed ID: 6395577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic synergy between Escherichia coli and Bacteroides fragilis: studies in an experimental mouse model.
    Verweij-van Vught AM; Namavar F; Sparrius M; Vel WA; MacLaren DM
    J Med Microbiol; 1985 Jun; 19(3):325-31. PubMed ID: 3892009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
    Rotstein OD; Kao J
    Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Bacteroides fragilis cellular components on chemotactic activity of polymorphonuclear leukocytes towards Escherichia coli.
    Namavar F; Verweij-Van Vught AM; Bal M; MacLaren DM
    J Med Microbiol; 1987 Sep; 24(2):119-24. PubMed ID: 3309320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.